SCHEMBL12608079

SCHEMBL12608079

CC1(C)CC(=O)N(C[C@@H](NC(=O)N[C@H]2CCCCCCCCC[C@@H](C(=O)C(=O)NCC3CC3)NC(=O)[C@@H]3[C@@H]4[C@H](CN3C2=O)C4(C)C)C(C)(C)C)C(=O)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12607144 0.93 — —
SCHEMBL8039214 0.92 — —
SCHEMBL12606746 0.92 — —
SCHEMBL12607494 0.92 — —
SCHEMBL12607434 0.92 — —
SCHEMBL8036262 0.92 — —
SCHEMBL12608446 0.91 — —
SCHEMBL12607184 0.91 — —
SCHEMBL7857573 0.91 — —
SCHEMBL8056194 0.91 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110150835-A1 Macrocyclic Inhibitors of Hepatitis C Virus NS3 Serine Protease SCHERING CORPORATION 2011-06-23 — — US disclosed
Send feedback